Press Releases
Chicago, May, 2011 - McGill University to partner with the International Dili Consortium to research the genetics of drug induced liver injury associated with tuberculosis therapy.
Chicago, February, 2011 - The International Serious Adverse Events Consortium (iSAEC) and the HMO Research Network (HMORN) collaborate to use electronic medical records to research genetics of drug-induced SAEs.
Chicago, February, 2011 - The International Serious Adverse Events Consortium (iSAEC) announces publication of whole genome study of drug induced serious skin rash.
Chicago, September, 2010 - Unique public/private partnership expands research to identify predictive genetic markers for drug-induced serious adverse events.
Chicago, September, 2010 - The International Serious Adverse Events Consortium (iSAEC) announces its fourth data release from its Global Research Collaboration to identify genetic markers related to drug induced serious adverse events.
Chicago, September, 2010 - The University of Liverpool and the International Serious Adverse Event Consortium to Partner on the development and execution of the International Hypersensitivity Consortium to research into the genetics of drug Induced hypersensitivity reactions.
Chicago, September, 2010 - Newcastle University and The International Serious Adverse Event Consortium to partner on the development and execution of the International DILI Consortium to research into the genetics of drug induced liver injury.
Chicago, June 17, 2010 - Broad Institute and the International Serious Adverse Event Consortium to partner on research into the genetics of augmentin induced liver injury.
Chicago, May 5, 2010 - Cerner Corporation and the International Serious Adverse Events Consortium to collaborate on studies to research the genetics of drug induced serious adverse events.
Chicago, January 27, 2010 - Duke University’s Center for Human Genome Variation and The International Serious Adverse Event Consortium to partner on research into the genetics of Clozapine induced Agranulocytosis.
Chicago, December, 2009 - The International Serious Adverse Events Consortium (iSAEC) announces its third data release relating to its global research collaboration to identify genetic markers related to drug induced serious adverse events.
Chicago, November, 2009 - PGxHealth, division of Clinical Data, Inc., contributes its Clozapine patient samples to the International Serious Adverse Event Consortium.
Chicago, October 21, 2009 – The International Serious Adverse Events Consortium and the HMO Research Network (HMORN) form research partnership to study how electronic medical records can address genetics of drug safety.
Chicago, May 31, 2009 – FDA and International Consortium Report New Data on Drug-Induced Liver Injury.
Chicago, April 8, 2009 – Academic Collaborator Partners With The International Serious Adverse Events Consortium (iSAEC) To Conduct Genomic Research On Drug Induced Cardiac Arrhythmia.
Chicago, February 9, 2009 – Press Release - FDA and International Serious Adverse Events Consortium Release First Data on Genetic Basis of Adverse Drug Events.
Chicago, June 25, 2008 – Press Release - Two academic collaborators join international Serious Adverse Events Consortium.
Chicago, May 29, 2008 – Press Release - Four leading companies join the international Serious Adverse Events Consortium.
Chicago, September 27, 2007 – Press Release - Official launch of the Serious Adverse Events Consortium.